I am puzzled by your comments

“ The first of several in the pipeline is PLUVICTO (PSMA Lutetium 177). (It is a 'first cousin of the substance in a PSMA PET-CT scan) Some well off individuals are resorting to medical tourism, going to Germany, India etc. to get the infusions of PLUVICTO. ”

Pluvicto has been available in the United States for years and is FDA approved and paid for by insurance. Actinium-225 Is what people are going over to Europe to get infusions of since it is not approved in the United States. I know somebody that actually went to Austria to have it done.

“Adding neoadjuvant ADT (androgen deprivation therapy) increases that sensitivity by 67%, (There is some thought that adding Nubeqa brings the sensitivity to 100% of the baseline?)“

I have looked into this and find that the percentage vary a lot Based on the case. Where did you get the information about ADT increasing sensitivity by 67%? I’d like to be able to quote that information and also the addition of Nubeqa.

What I have read is this

“ In summary, ADT enhances the effectiveness of radiation therapy however, the exact magnitude of the improvement varies depending on the specific clinical scenario.”